Guillaume Corpart
The geopolitical realignment reshaping Latin America’s medical equipment market has had far-reaching impacts across the region. Among the most significant is the rapid expansion of advanced medical device manufacturing in Latin American nations.
For years, nearshoring was largely associated with shifting labor-intensive manufacturing closer to the U.S. market. In the medical device sector, this traditionally meant tubing, surgical instruments, disposables, molded components, and other high-volume products that could be produced efficiently in Mexico or Central America and shipped north. Now, that legacy model is evolving.
As manufacturers seek to build greater supply chain resilience, reduce exposure to Asia, and bring production closer to end customers, Latin America is moving further up the medical technology value chain. Mexico and Costa Rica, in particular, are cultivating the specialized capabilities required to manufacture increasingly sophisticated devices—including cardiovascular technologies, neuromodulation components, robotic-assisted surgical equipment, and digitally connected medical equipment.
Advanced Manufacturing in the Mexican Market
Mexico is already the largest medical device exporter in Latin America and the eighth largest globally, with most of its production destined for the United States. U.S. government data estimates Mexico’s medical device exports reached $9.49 billion in 2024, up from $7.38 billion in 2020. [1] While this scale is impressive, the more critical story is the changing nature of that production.
Baja California remains the epicenter of Mexico’s medical device manufacturing ecosystem, while Chihuahua and other northern industrial hubs continue to attract significant investment and supplier activity. Meanwhile, the Mexican government is explicitly targeting advanced manufacturing, identifying medical devices alongside semiconductors, aerospace, and automotive as primary drivers for sophisticated industrial capabilities. [2] Consequently, the country’s manufacturing base can now handle precision machining, automated assembly, sterile production, specialized electronics, robust quality systems, and complex device integration.
This evolution is readily visible at the corporate level. BD, for example, opened a $38.6 million manufacturing facility in Tijuana designed specifically to produce medication-management technologies for global markets. [3] The facility manufactures automated dispensing cabinets, exporting finished systems to markets across North America, Europe, Africa, and Asia. [3]
This represents a fundamentally different strategic proposition than simply operating a low-cost assembly line. The facility seamlessly integrates manufacturing, global distribution, and proximity to the U.S. market within a single regional ecosystem. [3]
Costa Rica’s Move into MedTech
If Mexico represents the scale side of the equation, Costa Rica demonstrates how far Latin American manufacturing can move into highly specialized MedTech. Costa Rica has deliberately built a robust life-sciences ecosystem around multinational medical device OEMs, contract manufacturers, specialized suppliers, and a highly skilled technical workforce. According to PROCOMER, the medical device sector accounted for 48% of Costa Rica’s total goods exports in 2025, generating $10.927 billion and expanding by 25% over the previous year. [4]
Even more importantly, the nation’s manufacturing base has continuously evolved toward higher-value, high-complexity operations. [4] Today, Costa Rica’s medical device sector focuses on sophisticated therapeutic areas, including cardiovascular and vascular products, orthopedics, endoscopy, medication delivery systems, aesthetics, neuromodulation, neuroendovascular devices, and advanced surgical instruments. [5]
Producing these complex devices requires far more than low-cost labor; it demands validated processes, ISO cleanrooms, precision equipment, engineering expertise, stringent quality systems, and a workforce adept at operating in strictly regulated environments. To support these requirements, Costa Rica has actively invested in growing its talent pool, strengthening its local supplier network, and building institutional capacity for high-complexity operations. [4]
Major global players have taken note. Boston Scientific, for example, maintains extensive manufacturing facilities in Costa Rica. [6] Similarly, Cirtec Medical recently announced plans to more than double its operations in the country, citing surge demand across the neuromodulation, interventional, electrophysiology, and structural-heart markets. The company highlighted faster time-to-market, greater vertical integration, and expanded manufacturing capacity as key drivers behind the investment. [7]
Robotics, Neuromodulation, and the IoMT Supply Chain
The next phase of this industrial transition will be especially crucial as medical devices become increasingly software-intensive, connected, and automated. Robotic-assisted surgery offers a clear prime example. Contract manufacturers operating in Costa Rica are already producing precision components and complex assemblies for robotic surgical platforms. For instance, MICRO operates ISO-certified facilities in Costa Rica, leveraging advanced machining, molding, laser processing, and cleanroom assembly capabilities to support the robotic surgery market. [8]
Neuromodulation is another rapidly growing field. These technologies blend implantable components, micro-electronics, precision manufacturing, and sophisticated software. Notably, Cirtec’s local expansion specifically targets neuromodulation alongside interventional, electrophysiology, and structural-heart technologies. [7]
This same convergence is reshaping connected medical technologies. Costa Rica’s official technology strategy highlights digital health and emerging tech as core growth opportunities, while the national manufacturing ecosystem continues to integrate advanced production capabilities with digital innovation. [9]
This transformation is vital because the Internet of Medical Things (IoMT) is redefining the traditional medical device supply chain. Connected monitors, smart sensors, software-driven equipment, and intelligent devices demand cross-disciplinary expertise that transcends conventional manufacturing boundaries.
The Supply Chain Becomes Regional
As advanced manufacturing expands across the region, its economic and operational impacts extend far beyond individual factory walls. A high-tech medical device facility generates substantial demand for specialized tooling, precision machining, engineering, technical maintenance, specialized plastics, electronics, sterilization, packaging, testing, software, and quality-assurance services. Over time, these ancillary businesses coalesce around major manufacturing clusters to form self-sustaining ecosystems.
Mexico’s established trade infrastructure gives it a significant advantage. In 2024, Mexico exported approximately $15.5 billion in medical instruments and appliances, with $13 billion shipped to the United States alone. [10] Baja California accounted for roughly $5.19 billion of those international sales. [10]
Costa Rica is cultivating a similarly specialized ecosystem on a targeted scale. PROCOMER reports that the country’s medical device sector generated $10.927 billion in exports in 2025, supported by an expanding base of specialized suppliers and exporters. [4][11]
For healthcare providers and market players across Latin America, this shift brings distinct benefits: shorter distances between production and end-users, more resilient regional supply chains, and faster deployment of innovative technologies.
It also redefines the competitive landscape. Manufacturers choosing production locations no longer look strictly at labor wages and facility costs; they evaluate engineering talent, supplier density, regulatory frameworks, logistics, IP protection, quality standards, proximity to key markets, and scalability.
What Comes Next?
Nearshoring 2.0 is still unfolding, and Latin America will not replace Asia as a global MedTech manufacturing hub overnight. However, the trajectory is clear: the region’s leading hubs are transitioning from peripheral assembly outposts into strategically essential production and innovation centers in their own right.
As global MedTech leaders relocate their most advanced manufacturing operations to Latin America, regional supply chains and procurement timelines are shifting rapidly. For manufacturers, distributors, investors, and healthcare leaders, the key intelligence is no longer just what medical devices are entering Latin America—it is where those devices are manufactured, which components move through regional networks, and how these shifts redefine competitive dynamics across the market.
Are you tracking where advanced MedTech manufacturing is taking place and how it impacts regional import and export flows? Contact GHI today. Our granular trade data and custom market intelligence can help you map these emerging supply chains and secure a competitive edge in Latin America.
************
Sources:
https://www.trade.gov/country-commercial-guides/mexico-healthcare-products-services
https://www.trade.gov/market-intelligence/mexico-advanced-manufacturing
https://news.bd.com/2022-11-30-BD-Opens-New-38-6-Million-Medication-Management-Manufacturing-Facility-in-Tijuana
https://procomer.com/mdm-west-2026-procomer-sostuvo-encuentros-con-multinacionales-para-promover-inversion-de-alto-valor-en-costa-rica/
https://procomer.com/buyfromcostarica/manufacturing/wp-content/uploads/2024/08/Fly-Fichas-campana-Manufactura-2022-Medical-Devices.pdf
https://news.bostonscientific.com/expands-production-costa-rica
https://www.cirtecmed.com/news/cirtec-medical-expands-costa-rica-operations-to-support-increased-industry-demand
https://www.micro-co.com/robotic-assisted-surgery-2/
https://www.trade.gov/country-commercial-guides/costa-rica-strategic-and-emerging-technologies
https://www.economia.gob.mx/datamexico/en/profile/product/instruments-and-appliances-used-in-medical-sciences
https://procomer.com/comprador-internacional-industria-especializada/
